Armephaco JSC

Armephaco JSC EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Armephaco JSC (AMP.VN) as of Oct 19, 2026 is 23.46 B VND. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 12.63 B VND — a change of 85.69% (higher).

EBITDA

23.46 BVND

YoY

85.69%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Armephaco JSC is 2025 23.46 B VND. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Armephaco JSC was 2024 12.63 B VND. It decreases by 85.69% higher compared to the previous year.

The Armephaco JSC EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
35.62 B VND
Jan 1, 2019
44.00 B VND
Jan 1, 2020
35.41 B VND
Jan 1, 2021
23.24 B VND
Jan 1, 2022
18.01 B VND
Jan 1, 2023
15.61 B VND
Jan 1, 2024
12.63 B VND
Jan 1, 2025
23.46 B VND
The Armephaco JSC EBITDA history
YEAREBITDAYoY
23.46 BVND+85.69%
12.63 BVND-19.05%
15.61 BVND-13.34%
18.01 BVND-22.52%
23.24 BVND-34.35%
35.41 BVND-19.54%
44.00 BVND+23.54%
35.62 BVND-24.69%
47.29 BVND+20.20%
39.35 BVND+35.46%
29.05 BVND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Armephaco JSC Stock analysis

What does Armephaco JSC do? Armephaco JSC, listed on the Vietnamese stock market with ticker AMP.VN and ISIN VN000000AMP7, is headquartered in Hanoi, Vietnam. The company went public through an IPO on January 12, 2017. Armephaco engages in the manufacture and distribution of pharmaceutical products and medical equipment. Its product range includes glucose meters, sphygmomanometers, hospital beds, medical examination tables, and syringe destroyers. The company also produces and trades a variety of medicines, such as antibiotics, vitamins, pain relievers, antipyretics, gastrointestinal treatments, and anti-allergic medications. Armephaco operates within the pharmaceutical and medical equipment sector, though specific industry classifications are not detailed. The company's website is http://armephaco.com.vn/. As a publicly traded entity, Armephaco provides healthcare-related products and services to the Vietnamese market, focusing on both medical devices and pharmaceuticals. The company's operations are centered in Hanoi, where it manages its manufacturing and distribution activities. No additional details regarding founding year, key personnel, acquisitions, or financial figures are provided in the available information. Armephaco JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Armephaco JSC stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Armephaco JSC is 23.46 B VND in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Armephaco JSC changed from 12.63 B VND to 23.46 B VND, representing a 85.69% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Armephaco JSC since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s VND is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Armephaco JSC historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Armephaco JSC

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Armephaco JSC